Syngene Intl acquires its first U.S. biologics manufacturing facility

Syngene International acquired its first biologics manufacturing site in the United States at $36.5 million, a major expansion in the...

Govt invites funding proposals for Pharma MedTech sector

The Department of Pharmaceuticals has invited expression of interest from entities for the purpose of project funding under the Promotion...

Zydus Secures FDA Nod for Ketoconazole Shampoo Manufacturing

Zydus Lifesciences Limited has acquired final permission from the US Food and Drug Administration (USFDA) to manufacture 2% ketoconazole shampoo. According to the company's release today.

States to Set Up Centers for BioE3 Policy Implementation: Union Minister

Union Minister Jitendra Singh announced the establishment of BioE3 Cells in states to function as interconnected knowledge centers that will nurture the biomanufacturing sector of India. BioE3 Cells positioned between state and national stakeholders

Pharma Leaders View India's GCCs as Vital to Global Strategy, Growth and Innovation

India is fast emerging as a key hub for Global Capability Centers (GCCs), changing the way businesses do their work globally. Digital transformation and rapid advancements...

AstraZeneca Secures CDSCO Approval to Import SZC for Hyperkalaemia

The Central Drugs Standard Control Organization (CDSCO), Directorate General of Health Services, Government of India, has granted AstraZeneca Pharma India permission to import pharmaceutical formulations of new drugs for sale or distribution of oral

Glenmark Pharmaceuticals Rises 3.49% for Third Consecutive Session

Glenmark Pharmaceuticals Ltd's share price is trading at Rs 1380.8, up 3.49% on the day as of 12:49 eastern standard time on NSE. The stock has arisen significantly in the past...

India, Vietnam Strengthen Ties in Pharmaceutical Trade and Collaboration

A total of 39 Indian pharmaceutical firms engaged with over 50 Vietnamese partners, participating in productive discussions at an ‘India-Vietnam Business-to-Business (B2B)’ meeting focused on the pharmaceutical sector...

Indian Pharma Warns US Tariffs Could Raise Drug Costs, Cause Shortages

The Indian pharmaceutical industry has raised alarms over the potential imposition of US tariffs on pharmaceutical exports, warning that such a move could lead to increased drug costs and potential shortages for American consumers. Industry stalwarts

DCGI to Manufacturers of 2 FDCs to Submit Applications Within 3 Months

The Drugs Controller General of India (DCGI) has instructed the makers of two fixed dose combinations (FDCs) approved before 1988...

© 2025 India Pharma Outlook. All Rights Reserved.

Safety Monitoring